Nantong, China

YiXiang Lu


 

Average Co-Inventor Count = 7.1

ph-index = 1


Location History:

  • Jiangshu, CN (2015 - 2016)
  • Nantong, CN (2012 - 2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of YiXiang Lu

Introduction

YiXiang Lu is a prominent inventor based in Nantong, China. He has made significant contributions to the field of medical technology, particularly in the treatment of viral infections. With a total of five patents to his name, Lu's work focuses on innovative solutions for combating hepatitis B.

Latest Patents

One of YiXiang Lu's latest patents involves the development of RNA interference (RNAi) agents aimed at treating hepatitis B infection. This invention is directed towards utilizing RNAi agents to inhibit the expression of at least one Hepatitis B virus (HBV) gene. The agents comprise effector sequences that are complementary to predicted sequences transcribed from target regions. In various embodiments, these agents may contain multiple effector sequences that target the same or different regions of HBV genes, enhancing their effectiveness in treatment.

Career Highlights

Throughout his career, YiXiang Lu has worked with notable organizations such as Benitec Biopharma Limited and the Biocross Institute of Molecular Medicine. His experience in these companies has allowed him to advance his research and contribute to significant medical innovations.

Collaborations

YiXiang Lu has collaborated with several professionals in his field, including YunCheng Sun and York YuanYuan Zhu. These collaborations have fostered a productive environment for innovation and research.

Conclusion

YiXiang Lu's contributions to the field of hepatitis B treatment through his innovative RNAi agents highlight his role as a leading inventor in medical technology. His work continues to pave the way for advancements in viral infection treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…